Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
That number dropped from 16 in October 2025 after California, New Hampshire, Pennsylvania, and South Carolina eliminated obesity GLP-1 coverage largely due to state budget constraints
For questions about specific products, substances, and methods, contact USADAs Drug Reference Line at [email protected] or call (719) 785-2000, option 2
Human evidence [...] is still limited or in some cases non-existent for many of these compounds, so enthusiasm has often run ahead of clinical proof
Cost is the dominant constraint Sulfonylurea remains a reasonable second drug
US$ 27.04
US$ 29.31
US$ 25.08
US$ 27.88
